ESSA Pharma Inc. Daily Stock Analysis

Daily Stock Analysis, EPIX, ESSA Pharma Inc, priceseries

ESSA Pharma Inc. Daily Stock Analysis
Stock Information
Open
6.99
Close
6.94
High
7.13
Low
6.71
Previous Close
7.01
Daily Price Gain
-0.07
YTD High
14.88
YTD High Date
Jan 4, 2022
YTD Low
6.71
YTD Low Date
Mar 7, 2022
YTD Price Change
-7.50
YTD Gain
-51.94%
52 Week High
36.00
52 Week High Date
May 25, 2021
52 Week Low
6.71
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-22.20
52 Week Gain
-76.18%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 14. 2017
48.80
Mar 30. 2017
57.73
11 Trading Days
18.29%
Link
LONG
Aug 11. 2017
7.20
Aug 16. 2017
8.10
3 Trading Days
12.50%
Link
LONG
Sep 6. 2017
6.40
Sep 11. 2017
7.00
3 Trading Days
9.37%
Link
LONG
May 1. 2018
4.74
May 2. 2018
5.29
1 Trading Days
11.50%
Link
LONG
Aug 31. 2018
3.25
Sep 6. 2018
3.41
3 Trading Days
5.00%
Link
LONG
Jan 8. 2019
2.64
Jan 29. 2019
3.84
14 Trading Days
45.16%
Link
LONG
Aug 23. 2019
2.20
Sep 18. 2019
2.88
17 Trading Days
31.11%
Link
LONG
Oct 16. 2019
3.43
Nov 4. 2019
4.43
13 Trading Days
29.05%
Link
LONG
Apr 28. 2020
4.10
May 18. 2020
4.56
14 Trading Days
11.34%
Link
LONG
May 19. 2020
4.86
Jun 5. 2020
5.13
12 Trading Days
5.55%
Link
LONG
Jun 22. 2020
5.40
Jul 7. 2020
5.79
10 Trading Days
7.22%
Link
LONG
Dec 10. 2020
6.89
Jan 27. 2021
16.41
31 Trading Days
138.23%
Link
LONG
Jan 29. 2021
18.08
Feb 2. 2021
19.13
2 Trading Days
5.84%
Link
LONG
Feb 5. 2021
17.70
Feb 25. 2021
25.51
13 Trading Days
44.15%
Link
LONG
Apr 23. 2021
27.21
May 10. 2021
29.68
11 Trading Days
9.08%
Link
LONG
Oct 28. 2021
9.00
Nov 10. 2021
10.20
9 Trading Days
13.38%
Link
LONG
Nov 11. 2021
11.00
Nov 29. 2021
13.02
11 Trading Days
18.36%
Link
Company Information
Stock Symbol
EPIX
Exchange
NasdaqCM
Company URL
http://www.essapharma.com
Company Phone
781-761-7600
CEO
David R. Parkinson
Headquarters
Massachusetts
Business Address
4 MAGUIRE ROAD, LEXINGTON, MA 02421
Sector
Equity
Industry Category
-
Industry Group
-
CIK
0001027702
About

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It focuses on developing novel and proprietary therapies for the treatment of castration resistant prostate cancer (CRPC) in patients whose disease is progressing despite treatment with current therapies. ESSA Pharma's product candidate, EPI-506, expands the interval of time in which patients suffering from CRPC. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.

Description

ESSA Pharma Inc., a clinical-stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is headquartered in Vancouver, Canada.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading